Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Buprenorphine

Drug
Who is being recruted

Opioid-Related Disorders

Over 18 Years
How is the trial designed

Treatment Study

Phase 2
Interventional
Study Start: February 1992

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: August 17, 2005
Sourced from a government-validated database.Claim as a partner
Study start date: February 1, 1992Actual date on which the first participant was enrolled.

The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.

Official TitleBuprenorphine Detoxification With Two Types of Treatment. BBD IV 
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: August 17, 2005
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details
0
Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Over 18 YearsRange of ages for which participants are eligible to join.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Opioid-Related Disorders
Criteria
No eligibility criteria are available at this time.Please check with the study contact for more details. 
Anonymus Profile Image
Ensure optimum compatibilityAdd your profile to know your probability eligibility score.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives
Study Objectives
Primary Objectives


Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
Treatment Research CenterBurlington, United StatesSee the location

CompletedOne Study Center